Medical Device Network on MSN
Parkinson’s disease: neuromodulation and the search for disease modification
Neuromodulation is an adjunct to medication for Parkinson’s symptom management, with growing interest in whether it could one day contribute to disease-modifying therapies.
CFO transition -- Abhishek Jain announced retirement, with Nathan Smith appointed as incoming CFO effective Aug. 7.
Insilico Medicine (“Insilico”, 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven biotechnology ...
I used CNET's lab test data to calculate the cost-per-megabit for each router generation. The results showed me I was wrong about the value of Wi-Fi 7 routers. Joe Supan Senior Writer Joe Supan is a ...
Researchers at Skoltech have developed an ultra-compact electro-optic modulator based on silicon photonics and plasmonics ...
Understanding how drug discovery screening cascades are constructed and optimized is essential for minimizing false positives ...
AI images and video may be impressive, but they’re not ‘professional’-standard – an issue that a new research project seeks ...
Alzheimer’s disease, the leading cause of dementia, is a multifactorial disorder involving amyloid beta (Aβ) and tau ...
This manuscript presents a valuable analysis of how locomotion modulates the activity of different subtypes of cortical neurons in the mouse primary visual cortex, showing that locomotion more ...
An obsession with the numbers can sink your strategy. by Michael Harris and Bill Tayler Tying performance metrics to strategy has become an accepted best practice over the past few decades. Strategy ...
Physicists have spent the last 20 years pondering an apparent discrepancy between experimental results and theoretical ...
Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results